Population
In vitro preparations of human coronary and internal mammary arteries, and membranes prepared from human…
Design
Preclinical
Authors
Loading...
Supports nisoldipine coronary selectivity in preclinical models; leaves open clinical translation and superiority versus other calcium antagonists.
In vitro studies demonstrate that nisoldipine exhibits greater selectivity for human coronary arteries compared to other calcium antagonists like diltiazem, verapamil, and nifedipine.
Godfraind et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: